Alterations of p16/CDKN2, p53 and ras genes in oral squamous cell carcinomas and premalignant lesions

被引:47
作者
Matsuda, H [1 ]
Konishi, N [1 ]
Hiasa, Y [1 ]
Hayashi, I [1 ]
Tsuzuki, T [1 ]
Tao, M [1 ]
Kitahori, Y [1 ]
Yoshioka, N [1 ]
Kirita, T [1 ]
Sugimura, M [1 ]
机构
[1] NARA MED UNIV, DEPT ORAL & MAXILLOFACIAL SURG, KASHIHARA, NARA 634, JAPAN
关键词
oral carcinomas; p16/CDKN2; p53; ras;
D O I
10.1111/j.1600-0714.1996.tb01377.x
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Exons 1-3 of the p16/CDKN2 gene, exons 4-9 of the p53 gene and exons 1 and 2 of H-, K- and N-ras genes were screened for mutations by a combination of immunohistochemistry and single-strand conformational polymorphism (SSCP) analyses of polymerase chain reaction products from human surgical samples of bath frank oral squamous cell carcinomas and premalignant lesions. The samples included 20 squamous cell carcinomas, 10 epithelial dysplasias and 10 epithelial hyperplasias. No identifiable gene mutations were detected in any of the dysplasias or hyperplasias, while 2 (10%) deletions and 2 (10%) mutations of p16/CDKN2, along with 5 (25%) p53 mutations were found in the advanced carcinomas, yielding characteristic p16/CDKN2 and p53 changes. A mutation in the K-ras gene was found in single carcinoma and dysplastic samples. From the data, it can be argued that p16/CDKN2 and p53 mutations are relatively late occurrences in human oral tumorigenesis and that genetic alterations of the ras genes may not play a significant role in squamous neoplasia.
引用
收藏
页码:232 / 238
页数:7
相关论文
共 55 条
[1]  
AHSEE KW, 1994, CANCER RES, V54, P1617
[2]  
BENNETT WP, 1992, CANCER RES, V52, P6092
[3]  
BOS JL, 1989, CANCER RES, V49, P4682
[4]   ASSOCIATION BETWEEN CIGARETTE-SMOKING AND MUTATION OF THE P53 GENE IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK [J].
BRENNAN, JA ;
BOYLE, JO ;
KOCH, WM ;
GOODMAN, SN ;
HRUBAN, RH ;
EBY, YJ ;
COUCH, MJ ;
FORASTIERE, AA ;
SIDRANSKY, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (11) :712-717
[5]  
CASSON AG, 1991, CANCER RES, V51, P4495
[6]  
FIEED JK, 1991, BRIT J CANCER, V64, P573
[7]   INTRINSIC GTPASE ACTIVITY DISTINGUISHES NORMAL AND ONCOGENIC RAS-P21 MOLECULES [J].
GIBBS, JB ;
SIGAL, IS ;
POE, M ;
SCOLNICK, EM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (18) :5704-5708
[8]   MUTATION OF P53 IN PRIMARY BIOPSY MATERIAL AND CELL-LINES FROM HODGKIN DISEASE [J].
GUPTA, RK ;
PATEL, K ;
BODMER, WF ;
BODMER, JG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (07) :2817-2821
[9]  
GUSTERSON BA, 1991, ONCOGENE, V6, P1785
[10]   CLINICAL IMPLICATIONS OF THE P53 TUMOR-SUPPRESSOR GENE [J].
HARRIS, CC ;
HOLLSTEIN, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (18) :1318-1327